comparemela.com

Page 7 - Live On Air News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib

Strickler, Leung, Dasari, and O'Neill discuss adverse effect monitoring and management with standard agents for patients with colorectal cancer.

United statesNorth carolinaJohnh stricklerAshling wahnerMichael leungMargot oneillArvindn dasariUniversity of texas md anderson cancer centerDuke cancer instituteDivision of cancer medicineDuke cancer institute in durhamLive on airTaiho pharmaceuticalOnclive insideMedical oncologyCancer center

FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer

Dr Wainberg discusses the FDA approval of first-line NALIRIFOX for patients with metastatic pancreatic adenocarcinoma.

Los angelesUnited statesZeva wainbergAshling wahnerUniversity of californiaGastrointestinal oncology programLive on airOnclive on airApple podcastsGoogle podcastsAmazon music

Kang Highlights Considerations for the Integration of Torpialimab into Nasopharyngeal Carcinoma Clinical Practice

Dr Kang discusses the significance of the FDA approval of toripalimab for nasopharyngeal carcinoma and his anticipated use of the agent.

San franciscoUnited statesCoherus biosciencesCaroline seymourHyunseok hyu kangUniversity of californiaLive on airOnclive on airApple podcastsGoogle podcastsAmazon music

Tripathy Talks Through the Enduring Impact of the Miami Breast Cancer Conference

Dr Tripathy discusses the unique aspects of the Miami Breast Cancer Conference that make it worth returning to year after year.

United statesGina mauroDepartment of breast medical oncologyDivision of cancer medicineUniversity of texas md anderson cancer centerLive on airDebu tripathyBreast medical oncologyCancer medicineCancer centerAnnual miami breast cancer conferenceMiami breastFontainebleu miami beachOnclive on airApple podcastsGoogle podcasts

Kitco and Patel Emphasize the Importance of GVHD Research and Awareness

Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.

United statesMonroe carell jrCarriel kitkoSagars patelCaroline seymourPediatric stem cell transplantation programMedia relationships for the division of hematologyLive on airIngram professorPediatric oncologyMonroe carellMedia relationshipsUtah huntsman cancer instituteSalt lakeSecond annualOnclive on air

vimarsana © 2020. All Rights Reserved.